Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares shot up 4% during trading on Monday . The stock traded as high as $119.00 and last traded at $117.99. 365,144 shares traded hands during trading, a decline of 86% from the average session volume of 2,548,667 shares. The stock had previously closed at $113.44.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
The stock has a 50 day moving average of $107.73 and a 200-day moving average of $118.33.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LABU. Tidal Investments LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 1st quarter worth about $1,858,000. McGuire Investment Group LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 11.4% during the 1st quarter. McGuire Investment Group LLC now owns 4,594 shares of the company’s stock valued at $610,000 after acquiring an additional 470 shares during the period. Gainplan LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 1st quarter valued at about $664,000. TB Alternative Assets Ltd. acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 1st quarter valued at about $10,180,000. Finally, Traynor Capital Management Inc. grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 118.0% during the 1st quarter. Traynor Capital Management Inc. now owns 5,804 shares of the company’s stock valued at $770,000 after acquiring an additional 3,142 shares during the period.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Stock Market Upgrades: What Are They?
- RXO Shares Surge Following New Acquisition Deal
- Industrial Products Stocks Investing
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
